跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Lucazine - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Lucazine
Approved
STANDARD
Lucazine
Ratnamani Healthcare Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
82e096b14387e04c
Company
Ratnamani Healthcare Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
82e096b14387e04c
Drug Approval Philippines Name
Lucazine
Product Name
Lucazine
Registration Number
DRP-12920
Brand Name
Lucazine
Generic Name
Montelukast + Levocetirizine
Dosage Form
Film-Coated Tablet
Dosage Strength
10 mg/5 mg
Manufacturer
Ratnamani Healthcare Pvt. Ltd.
Importer
Medinova Pharmaceutical Inc.
Distributor
Medinova Pharmaceutical Inc.
Issuance Date
28 October 2022
Expiry Date
28 October 2027
Pharmacologic Category
Leukotriene Receptor Antagonist-Antihistamine Combination
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
82e096b14387e04c
Type
Standard
Back to Philippines FDA Approvals